Lopressor dosage forms and strengths: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
FDA Package Insert for '''Lopressor''' contains no information regarding ''Dosage Forms and Strengths''.
FDA Package Insert for '''Lopressor''' contains no information regarding ''Dosage Forms and Strengths''.


==References==
{{Reflist}}
{{FDA}}
[[Category:Antianginals]]
[[Category:Antiarrhythmic agents]]
[[Category:Antihypertensive agents]]
[[Category:Antimigraine drugs]]
[[Category:Beta blockers]]
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Revision as of 00:46, 14 March 2014

Metoprolol
Clinical data
Trade namesLopressor, Toprol-xl
AHFS/Drugs.comMonograph
MedlinePlusa682864
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • AU: C
  • US: C (Risk not ruled out)
Routes of
administration
Oral, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability12%
MetabolismHepatic via CYP2D6, CYP3A4
Elimination half-life3-7 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H25NO3
Molar mass267.364 g/mol
3D model (JSmol)
Melting point120 °C (248 °F)
  (verify)

FDA Package Insert for Lopressor contains no information regarding Dosage Forms and Strengths.

References

Adapted from the FDA Package Insert.